Earnings Ahead

CDTX - Cidara Therapeutics, Inc.

1.09 -0.02 -1.8

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

About

Profile


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CDTX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Cidara off 27% despite FDA nod amid selloff in antifungal space
  • Cidara Therapeutics GAAP EPS of -$0.19 misses by $0.04, revenue of $10.22M misses by $0.35M
  • Cidara stock dips amid FDA approval of antifungal drug Rezzayo
  • Deadly fungal infection sweeps across U.S.
  • Cidara extends gains ahead of FDA decision on antifungal therapy
  • CDTX, PTGX and TAST among premarket gainers
  • Cidara secures capital raise of $17M; stock down 18%
  • Cidara stock slumps ~15% on common stock, preferred shares offerings
  • Cidara Therapeutics adds 31% on mid-stage data of flu prophylactic drug
  • Cidara stock pops as CD388 helps cut influenza risk in phase 2a trial
  • Cidara Therapeutics regains compliance with Nasdaq's minimum bid price rule
  • Cidara jumps 17% after FDA AdCom nod for antifungal drug
  • Cidara on watch as FDA docs are released ahead of AdCom on antifungal drug
  • Cidara Therapeutics GAAP EPS of $0.17 beats by $0.10, revenue of $40.74M beats by $18.06M
  • Cidara Therapeutics receives $11.1M milestone payment from Mundipharma
  • Cidara spikes on $11M milestone payment from partner Mundipharma
  • Cidara begins dosing of antiviral CD388 in trial for preventing influenza
  • Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09, revenue of $6.22M beats by $0.01M
  • Cidara stock soars 29% on FDA approval filing for rezafungin, sale of US rights for drug for $30M upfront
  • Catalyst watch: Levi Strauss earnings, Ford sales and travel stocks put to the test
PEERS

Earnings History

Date EPS / Forecast Revenue / Forecast
November 10, 2021 -0.37 / -0.3617 7.08M / 2.94M Beat!
August 12, 2021 0.18 / -0.2167 32.86M / 12.13M Beat!
May 13, 2021 -0.39 / -0.335 2.41M / 7.88M
February 25, 2021 -0.49 / -0.24 3.73M / 12.95M
November 5, 2020 -0.41 / -0.4035 2.42M / 4.89M
August 13, 2020 -0.45 / -0.28 3.39M / 5.29M
May 13, 2020 -0.46 / -0.34 2.53M / 2.25M Beat!
March 4, 2020 -0.42 / -0.43 1.82M / 3.63M
November 8, 2019 0.08 / -0.56 19.1M / 7.5M Beat!
August 8, 2019 -0.49 / -0.57 19.10M / 750K
May 9, 2019 -0.6 / -0.60 19.10M / 750K
February 28, 2019 -0.44 / -0.59 19.10M / - Beat!
November 8, 2018 -0.49 / -0.6 - / -
August 8, 2018 -1.13 / -0.66 - / -
May 10, 2018 -0.8 / -0.64 - / 0.26M
November 8, 2017 -0.73 / -0.94 - / -
August 10, 2017 -0.99 / -0.94 - / -
May 11, 2017 - / -0.88 - / -
March 16, 2017 -0.88 / -0.81 - / -
November 21, 2016 -0.88 / -0.81 - / -
August 9, 2016 -0.85 / -0.82 - / -
Date Price Open High Low Vol Change ER
Aug 7, 2023 0.93 0.98
1
0.91
767K -5.1%
Aug 4, 2023 0.98 1
1.01
0.94
518K -3.92%
Aug 3, 2023 1.02 1.03
1.06
1.02
247K -1.92%
Aug 2, 2023 1.04 1.03
1.07
1.01
710K 0%
Aug 1, 2023 1.04 1.05
1.08
0.98
818K 4%
 
Jul 31, 2023 1 0.98
1.02
0.96
549K 3.09%
Jul 28, 2023 0.97 0.94
1.01
0.94
303K 3.19%
Jul 27, 2023 0.94 0.99
1.02
0.93
461K -6%
Jul 26, 2023 1 0.97
1.02
0.93
611K 4.17%
Jul 25, 2023 0.96 0.99
1.03
0.96
367K -2.04%
Jul 24, 2023 0.98 1.04
1.04
0.97
775K -7.55%
Jul 21, 2023 1.06 1.05
1.08
0.9
2.5M -3.64%
Jul 20, 2023 1.1 1.16
1.16
1.1
411K -4.35%
Jul 19, 2023 1.15 1.15
1.18
1.14
316K -0.86%
Jul 18, 2023 1.16 1.13
1.16
1.12
358K 2.65%
Jul 17, 2023 1.13 1.1
1.14
1.1
592K 2.73%
Jul 14, 2023 1.1 1.11
1.12
1.09
593K -2.65%
Jul 13, 2023 1.13 1.1
1.13
1.1
428K 2.73%
Jul 12, 2023 1.1 1.1
1.12
1.1
302K 0%
Jul 11, 2023 1.1 1.13
1.13
1.08
462K -0.9%
Jul 10, 2023 1.11 1.12
1.13
1.1
351K 0%
Jul 7, 2023 1.11 1.11
1.12
1.09
294K 0%
Jul 6, 2023 1.11 1.1
1.12
1.08
450K -0.89%
Jul 5, 2023 1.12 1.12
1.17
1.08
627K -0.88%
Jul 3, 2023 1.13 1.12
1.14
1.11
248K 0%
Jun 30, 2023 1.13 1.12
1.15
1.11
318K 0%
Jun 29, 2023 1.13 1.11
1.13
1.1
300K 1.80%
Jun 28, 2023 1.11 1.1
1.13
1.06
399K 1.83%
Jun 27, 2023 1.09 1.11
1.12
1.04
902K -1.8%
Jun 26, 2023 1.11 1.17
1.17
1.11
355K -4.31%
Jun 23, 2023 1.16 1.15
1.18
1.12
949K -0.85%
Jun 22, 2023 1.17 1.21
1.22
1.1
1.7M 6.36%
Jun 21, 2023 1.1 1.11
1.16
1.1
341K -2.65%
Jun 20, 2023 1.13 1.1
1.15
1.09
574K 1.80%
Jun 16, 2023 1.11 1.15
1.21
1.11
1.2M -2.63%
Jun 15, 2023 1.14 1.15
1.18
1.13
826K -0.87%
Jun 14, 2023 1.15 1.2
1.2
1.13
964K -4.17%
Jun 13, 2023 1.2 1.22
1.25
1.2
508K -2.44%
Jun 12, 2023 1.23 1.21
1.26
1.21
558K 1.65%
Jun 9, 2023 1.21 1.25
1.26
1.2
586K -2.42%
Jun 8, 2023 1.24 1.27
1.27
1.22
688K -2.36%
Jun 7, 2023 1.27 1.32
1.33
1.24
1.0M -3.05%
Jun 6, 2023 1.31 1.3
1.34
1.3
473K 0.77%
Jun 5, 2023 1.3 1.32
1.38
1.27
1.2M -0.76%
Jun 2, 2023 1.31 1.32
1.34
1.28
496K -0.76%
Jun 1, 2023 1.32 1.33
1.36
1.29
479K -0.75%
May 31, 2023 1.33 1.33
1.35
1.23
1.0M 3.10%
May 30, 2023 1.29 1.36
1.37
1.28
701K -5.15%
May 26, 2023 1.36 1.3
1.36
1.29
906K 6.25%
May 25, 2023 1.28 1.36
1.37
1.26
698K -4.48%
May 24, 2023 1.34 1.35
1.37
1.28
618K -2.19%
May 23, 2023 1.37 1.4
1.48
1.31
1.1M -3.52%
May 22, 2023 1.42 1.3
1.44
1.3
1.4M 9.23%
May 19, 2023 1.3 1.26
1.36
1.26
909K 2.36%
May 18, 2023 1.27 1.35
1.35
1.25
1.4M -5.93%
May 17, 2023 1.35 1.32
1.37
1.25
1.4M 2.27%
May 16, 2023 1.32 1.36
1.42
1.29
2.3M -2.94%
May 15, 2023 1.36 1.14
1.39
1.09
3.3M 16.24%
May 12, 2023 1.17 1.27
1.29
1.13
5.7M -0.85%
May 11, 2023 1.18 1.14
1.19
1.11
1.2M 0%